Symbiotec Pharmalab IPO Subscription Status Today (Live Update) 2026

Symbiotec Pharmalab IPO Subscription Status: Symbiotec Pharmalab IPO has been subscribed 11.62x overall on Day 4 as on 27-Aug (12:23 pm). The Retail portion has been subscribed 7.98x, QIB (Ex-Anchor) has been subscribed 0.67x, and NII has been subscribed 29.79x.

Symbiotec Pharmalab IPO will open for subscription on August 24, 2026, and close August 27, 2026.

Symbiotec Pharmalab IPO Reserved In this IPO 50.00% shares are reserved for QIBs, 15.00% for NIIs and 35.00% for the retail category. To know the Symbiotec Pharmalab IPO subscription status, you can check the subscription data live given below.

Symbiotec Pharmalab IPO Subscription Live [Day 4]

27-Aug (12:23 pm)

Category	Share Offerd	Share Bid For	Subscribed
QIB [Ex Anchor]	35,50,608	23,76,450	0.67x
NII	26,62,955	7,93,23,765	29.79x
bNII [>10L]	17,75,303	6,35,96,865	35.82x
sNII [<10L]	8,87,652	2,45,11,170	27.61x
Retail	62,13,562	4,95,83,100	7.98x
Employee	33,408	3,06,390	9.17x
Total	1,24,60,533	14,47,54,440	11.62x

Note: Symbiotec Pharmalab IPO Subscription Figures Are Regularly Updated With The Latest Available Exchanges (NSE & BSE) Data.

Read Also: Symbiotec Pharmalab IPO GMP

Symbiotec Pharmalab IPO Day Wise Subscription Data

Symbiotec Pharmalab IPO Subscription data is automatically saved by day when the subscription expires after 6:00 pm in the table below.

Category	Day 1	Day 2	Day 3	Day 4
QIB [Ex Anchor]	0.37x	0.57x	0.62x	0.00x
NII	1.10x	3.16x	12.86x	0.00x
bNII [>10L]	0.82x	2.59x	11.90x	0.00x
sNII [<10L]	1.66x	4.30x	14.78x	0.00x
Retail	1.01x	2.22x	5.38x	0.00x
Employee	1.65x	3.19x	6.25x	0.00x
Total	0.85x	1.95x	5.62x	0.00x

Symbiotec Pharmalab IPO [Share Offerd]

Category	Shares	Ammount
QIB	88,76,517	₹677.00 Cr.
NII	26,62,955	₹263.10 Cr.
Retail	62,13,562	₹613.90 Cr.
Employee	33,408	₹3.30 Cr.
Total	1,77,86,442	₹1,757.30 Cr.

Types of Symbiotec Pharmalab IPO Subscription

There are mainly three categories of subscription for Symbiotec Pharmalab IPO, which are determined based on the type of investor applying:

1. Retail Investors (RI):
   • Retail Investors are individual investors who apply for the IPO shares for their personal accounts, typically in amounts that do not exceed a specified limit (usually ₹2 lakh).
   • This category is highly important for IPOs, as retail investors often comprise a significant portion of the total demand.
   • If the IPO is oversubscribed in this category, the allotment is done via a lottery system, where each retail investor has an equal chance of receiving shares.
2. Qualified Institutional Buyers (QIBs):
   • QIBs are institutional investors such as mutual funds, insurance companies, and pension funds. They are typically large entities with significant capital to invest in the IPO.
   • The QIB category often gets a significant portion of the overall offering, and it’s considered a critical factor for the success of the IPO.
   • The subscription rate for QIBs is usually higher than for retail investors, and they generally receive priority in allotment.
3. Non-Institutional Investors (NIIs):
   • NIIs include high-net-worth individuals (HNIs) or corporates that apply for IPO shares in larger quantities, typically exceeding ₹2 lakh.
   • Like QIBs, the NII category is a significant driver of an IPO’s success, especially if the retail category is under-subscribed.
   • They are generally allocated shares after the retail and QIB categories have been allotted, and sometimes the shares allotted to this category may be on a pro-rata basis if there is oversubscription.

Symbiotec Pharmalab IPO Subscription Status FAQs

Thank You…